RRAD and colorectal carcinoma: In vitro analysis could not reflect the interaction between tumor cells and tumor microenvironment, so mice bearing tumors derived from GC cells and CRC cells were treated to determine the anti-tumor effect of RRAD inhibition in vivo (Fig. 4).